Immunomic Therapeutics, Inc.

New Filing
CIK: 0001543256·Biotechnology·DELAWARE·Filed: Feb 26, 2020
Total Offering

$60,000,000

Amount Sold

$10,000,000

Investors

1

First Sale

Feb 18, 2020

Offering Details

Type
Equity, Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
WILLIAM G. HEARL
Related Person
C. ERIC WINZER
Related Person
MICHAEL D. LACK
Related Person
JAMES W. WISHART
Related Person
RONALD P. THIBOUTOT
Related Person

Company

Immunomic Therapeutics, Inc.

ATTN: WILLIAM HEARL, 15010 BROSCHART RD.

ROCKVILLE, MD, 20850

301-728-0860

SEC Filing

0001543256-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Immunomic Therapeutics, Inc. Form D Filing — $60,000,000 | FilingFlow